Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Craig C. Parker

Pharmaceutical Sciences
Jazz Pharmaceuticals


Craig C. Parker was appointed our Senior Vice President, Corporate Development as of August 2014. From December 2012 to July 2014, he was Executive Vice President, Corporate Development and Scientific Affairs at Geron Corporation. Prior to joining Geron, from August 2011 until November 2012, Mr. Parker was Senior Vice President, Strategy and Corporate Development at Human Genome Sciences, Inc., a biopharmaceutical company that was acquired by GlaxoSmithKline in 2012. From February 2009 to January 2010, he was Senior Vice President of Corporate Development and Finance at Proteolix, a clinical development stage biotechnology company developing novel oncology drug candidates. From December 1999 to June 2001, Mr. Parker served as Senior Vice President and General Manager at Immunex Corporation. Prior to that, Mr. Parker served 12 years as a Wall Street research analyst. Mr. Parker currently serves on the Board of Directors of vTv Therapeutics and the Scientific Advisory Board of the Life Sciences Institute at the University of Michigan. Mr. Parker received a B.S. in Biological Sciences from the University of Chicago and an M.B.A. from the Stephen M. Ross School of Business of the University of Michigan.

Research Interest

pharmaceutical industry

Global Experts from Ireland

Global Experts in Subject

Share This Profile